Using the COPE intervention for family caregivers to improve symptoms of hospice homecare patients: a clinical trial.

Using the COPE intervention for family caregivers to improve symptoms of hospice homecare patients: a clinical trial. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Using the COPE intervention for family caregivers to improve symptoms of hospice homecare patients: a clinical trial. Abstract Text:

Susan C McMillan,Brent J Small,

PURPOSE/OBJECTIVES: To test an intervention for hospice caregivers designed to help them better manage symptoms experienced by patients with cancer. DESIGN: A three-group comparative design with repeated measures. SETTING: A large nonprofit hospice that primarily provides home care. SAMPLE: 329 hospice homecare patients with cancer and their caregivers were randomized into three groups: a control group (n = 109) receiving standard care, a group (n = 109) receiving standard care plus friendly visits, and a group (n = 111) receiving standard care plus the COPE intervention. METHODS: Caregivers received experimental training in the COPE intervention (creativity, optimism, planning, expert information) over nine days to assist with symptom management. MAIN RESEARCH VARIABLES: Intensity of pain, dyspnea, and constipation, overall symptom distress, and quality of life (QOL). Data were collected on admission and days 16 and 30. FINDINGS: Although symptom intensity for three target symptoms did not decrease, symptom distress was significantly improved (p = 0.009) in the COPE intervention group. QOL was not significantly different. CONCLUSIONS: Symptom distress, a measure that encompasses patient suffering along with intensity, was significantly decreased in the group in which caregivers were trained to better manage patient symptoms. IMPLICATIONS FOR NURSING: The COPE intervention is effective and immediately translatable to the bedside for hospice homecare patients with advanced cancer.

Using the COPE intervention for family caregivers to improve symptoms of hospice homecare patients: a clinical trial. Publishing Authors By Initials

SC McMillan,BJ Small,

For similar geographic locations: americas: north america: united states research abstracts see: geographic locations: americas: north america: united states research

PUBMED ID PMID:

MEDLINE DATE:

Using the COPE intervention for family caregivers to improve symptoms of hospice homecare patients: a clinical trial. Journal Published:

PUBLICATION TYPE: Research Support, N.I.H., Extr

Journal: Oncology nursing forum

VOLUME: 34

Page Numbers: 313-21

Journal Abbreviation:

ISSN: 1538-0688

DAY: 3

MONTH: Mar

YEAR: 2007

Using the COPE intervention for family caregivers to improve symptoms of hospice homecare patients: a clinical trial. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 7809033

Using the COPE intervention for family caregivers to improve symptoms of hospice homecare patients: a clinical trial. Keywords Mesh Terms:

KEYWORDS: United States

MESH TERMS: psychology

Chemical & Substance for Abstract: Using the COPE intervention for family caregivers to improve symptoms of hospice homecare patients: a clinical trial. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Using the COPE intervention for family caregivers to improve symptoms of hospice homecare patients: a clinical trial.

AFFILIATION: College of Nursing, University of South Florida, Tampa, FL, USA. smcmilla@health.usf.edu

Country: United States

AGENCY: United States NCI

GRANT: 1 R01 CA77307-01A3

ACRONYM: CA

MEDLINETA: Oncol Nurs Forum

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Using the COPE intervention for family caregivers to improve symptoms of hospice homecare patients: a clinical trial Related Publications

• 281.
• Activity of second-line chemotherapy in docetaxel-refractory hormone-refractory prostate cancer patients : randomized phase 2 study of ixabepilone or mitoxantrone and prednisone.
• Adrenal androgen levels as predictors of outcome in prostate cancer patients treated with ketoconazole plus antiandrogen withdrawal: results from a cancer and leukemia group B study.
• An in vivo correlate of exercise-induced neurogenesis in the adult dentate gyrus.
• Blank augmentation protocol for improving the robustness of multivariate calibrations.
• CA3 NMDA receptors are required for experience-dependent shifts in hippocampal activity.
• Cognitive deficits in preclinical Alzheimer's disease and vascular dementia: patterns of findings from the Kungsholmen Project.
• Constitutive Fms-like tyrosine kinase 3 activation results in specific changes in gene expression in myeloid leukaemic cells.
• Globally distributed mycobacterial fish pathogens produce a novel plasmid-encoded toxic macrolide, mycolactone F.
• Hearing lips and seeing voices: how cortical areas supporting speech production mediate audiovisual speech perception.
• Imaging the earliest stages of Alzheimer's disease.
• Imaging-guided microarray: isolating molecular profiles that dissociate Alzheimer's disease from normal aging.
• Jagged-1hi or Delta-1hi thymic stromal cell populations can trigger acquisition of Thy-1 and loss of B220.
• Longitudinal mapping of mouse cerebral blood volume with MRI.
• Molecular evolution of the Li/li chemical defence polymorphism in white clover (Trifolium repens L.).
• Photoacoustic characterization of protein dynamics following CO photodetachment from fully reduced bovine cytochrome c oxidase.
• Plasma inhibitory activity (PIA): a pharmacodynamic assay reveals insights into the basis for cytotoxic response to FLT3 inhibitors.
• Prolonged exposure to FLT3 inhibitors leads to resistance via activation of parallel signaling pathways.
• Psychosocial functioning of adults who experienced substance use disorders as adolescents.
• Quantitative determination of ethanol in heated plumes by passive Fourier transform infrared remote sensing measurements.
• Repetition suppression for spoken sentences and the effect of task demands.
• Screening for depressive symptoms in patients with unresectable lung cancer.
• Selective expression of an aP2/Fatty Acid Binding Protein 4-Cre transgene in non-adipogenic tissues during embryonic development.
• Spectral simulation methodology for calibration transfer of near-infrared spectra.
• Speech-associated gestures, Broca's area, and the human mirror system.
• Task-dependent changes in brain activation following therapy for nonfluent aphasia: discussion of two individual cases.
• The mind of expert motor performance is cool and focused.
• Transgenic mice expressing Tel-FLT3, a constitutively activated form of FLT3, develop myeloproliferative disease.
• Trying to detect taste in a tasteless solution: modulation of early gustatory cortex by attention to taste.
• Using the COPE intervention for family caregivers to improve symptoms of hospice homecare patients: a clinical trial.